Emergency pharmaceutical - six (6) kimmtrak / tebentafusp 100MCG
Ended Awarded Last action
- Contract number
- 36C26125N0314
- Awardee
-
Immunocore Commercial LLC UEI FZLMFD51RYN1
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $88,358
Award facts
- Contract value 100% obligated
- $88,358.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$444 | |
| Original award | $88,802 |
About this award
On January 17, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 21, awarded a delivery order contract valued at $88,358.10 to Immunocore Commercial LLC for the emergency procurement of six units of KIMMTRAK (tebentafusp) 100 micrograms. The contract is structured as a firm fixed-price delivery order with no set-aside designation and carries an ultimate completion date of March 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania. This award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and leverages Immunocore Commercial LLC's existing multiple-award FSS contract with the VA.
Immunocore Commercial LLC, a foreign-owned pharmaceutical manufacturer specializing in KIMMTRAK production, has established itself as a consistent supplier to the VA system through multiple contract vehicles. The company holds a $225,000 FSS indefinite delivery contract through November 14, 2028, and more recently secured a $4,000,000 single-award Blanket Purchase Agreement from the National Acquisition Center with completion through April 9, 2026. The emergency nature of this delivery order reflects the VA's urgent healthcare needs for this specialized hematology-related injectable pharmaceutical, demonstrating VISN 21's reliance on Immunocore's established supply chain for critical pharmaceutical products.
Quick answers
Who was awarded contract 36C26125N0314?
36C26125N0314 was awarded to Immunocore Commercial LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on January 17, 2025.
How much is contract 36C26125N0314 worth?
The government has obligated $88,358 on 36C26125N0314.
Is contract 36C26125N0314 an order under another contract?
Yes. 36C26125N0314 is a delivery order under 36F79724D0026, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125N0314 competed?
The extent of competition for 36C26125N0314 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award